Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02102230 · ClinicalTrials.gov registry record · NA
CBT-I for Cannabis Use
A NA study, sponsored by VA Office of Research and Development.
- Terminated
- Registry status
- NA
- Development phase
- 111
- Enrollment target
NCT02102230: Clinical Trial NA study, sponsored by VA Office of Research and Development.
NCT02102230 is a NA study that was terminated before completion, run by VA Office of Research and Development. The registered enrollment target is 111 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02102230, a NA study, was terminated before completion, sponsored by VA Office of Research and Development.
- TERMINATED
- Registry status
- NA
- Development phase
- 111 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the efficacy of a group-based behavioral sleep intervention, and the incremental benefit provided by an adjunct sleep mobile app, on cannabis and sleep outcomes among cannabis dependent Veterans.
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy for Insomnia (CBT-I)
- BEHAVIORAL Cognitive Behavioral Therapy for Insomnia Plus Mobile App (CBT-I-MA)
- BEHAVIORAL Desensitization Treatment for Insomnia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2014-11-03 |
| Est. Completion | 2017-03-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02102230
The ClinicalTrials.gov registry entry for NCT02102230 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 111 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Cognitive Behavioral Therapy for Insomnia (CBT-I) is the first listed.
NCT02102230 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02102230 about?
NCT02102230 is a clinical study titled "CBT-I for Cannabis Use". The purpose of this study is to investigate the efficacy of a group-based behavioral sleep intervention, and the incremental benefit provided by an adjunct sleep mobile app, on cannabis and sleep outcomes among cannabis dependent Veterans.
What is the current status of trial NCT02102230?
This trial is currently terminated. It is a NA study. The enrollment target is 111 participants. The study started on 2014-11-03. Estimated completion is 2017-03-24.
What interventions are being tested in trial NCT02102230?
The interventions under investigation include: Cognitive Behavioral Therapy for Insomnia (CBT-I) (BEHAVIORAL), Cognitive Behavioral Therapy for Insomnia Plus Mobile App (CBT-I-MA) (BEHAVIORAL), Desensitization Treatment for Insomnia (BEHAVIORAL).
Who is sponsoring clinical trial NCT02102230?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.